Bloomberg Markets Eli Lilly Set to Back Aktis Oncology’s Upsized $318 Million IPO
Aktis Oncology Inc. increased the size of its initial public offering by 50%, and drew interest from Eli Lilly & Co. for $100 million of shares in the listing.
Aktis Oncology Inc. increased the size of its initial public offering by 50%, and drew interest from Eli Lilly & Co. for $100 million of shares in the listing.